Page last updated: 2024-11-05

n-acetylanthranilic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-acetylanthranilic acid: degradation product or quinaldine; RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-acetylanthranilic acid : An amidobenzoic acid consisting of anthranilic acid carrying an N-acetyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6971
CHEBI ID36555
SCHEMBL ID110042
MeSH IDM0185850

Synonyms (42)

Synonym
o-acetoaminobenzoic acid
CHEBI:36555
o-acetamidobenzoic acid
nsc 17831
nsc4000
2-(acetylamino)benzoic acid
anthranilic acid, n-acetyl-
acetylanthranilic acid
nsc-4000
n-(acetylamino)benzoic acid
2-acetamidobenzoic acid
benzoic acid, 2-(acetylamino)-
2-carboxyacetanilide
o-acetoaminobenozic acid
inchi=1/c9h9no3/c1-6(11)10-8-5-3-2-4-7(8)9(12)13/h2-5h,1h3,(h,10,11)(h,12,13
nsc-17831
nsc17831
OPREA1_069366
89-52-1
2-(acetylamino)-benzoic acid
n-acetylanthranilic acid
C06332
n-acetylanthranilic acid, 99%
MAYBRIDGE1_000763
AKOS000280893
HMS543K15
zz8 ,
unii-p1ie9j75c2
p1ie9j75c2 ,
A0078
BBL009698
STL141050
FT-0610932
2-acetamidobenzoicacid
SCHEMBL110042
2-acetylamino benzoic acid
n-acetyl anthranilic acid
DTXSID9058991
o-acetylaminobenzoic acid
o-acetamido benzoic acid
dea no. 8522
Q6951344
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amidobenzoic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index56.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]